<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; squamous cell carcinoma</title>
	<atom:link href="http://oralcancernews.org/wp/tag/squamous-cell-carcinoma/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Mon, 21 May 2012 12:57:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Genes May Link Disparate Diseases</title>
		<link>http://oralcancernews.org/wp/genes-may-link-disparate-diseases/</link>
		<comments>http://oralcancernews.org/wp/genes-may-link-disparate-diseases/#comments</comments>
		<pubDate>Wed, 02 May 2012 17:33:24 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Crohn's disease]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[Johns Hopkins University]]></category>
		<category><![CDATA[National Academy of Science]]></category>
		<category><![CDATA[National Institutes of Health]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[throat cancer]]></category>
		<category><![CDATA[Type 2 diabetes]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12970</guid>
		<description><![CDATA[Source: The Wall Street Journal Diseases that strike different parts of the body—and that don&#8217;t seem to resemble each other at all—may actually have a lot in common. Scientists have identified the genetic basis for many separate diseases. Now, some researchers are looking at how the genes interact with each other. They are finding that [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/genes-may-link-disparate-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>April: Oral Cancer Awareness Month</title>
		<link>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/</link>
		<comments>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/#comments</comments>
		<pubDate>Mon, 02 Apr 2012 16:47:20 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[OCF In The News]]></category>
		<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral cancer awareness month]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[The American Cancer Society]]></category>
		<category><![CDATA[The Oral Cancer Foundation]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12733</guid>
		<description><![CDATA[Source: Aspen Dental April is Oral Cancer Awareness Month. According to Brian Hill, founder and executive director of the Oral Cancer Foundation, as many as 40,000 people in the United States will be told they have oral or pharyngeal cancer in 2012. Some of them may be sitting in your dental chair today. With one [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/april-oral-cancer-awareness-month/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Epidermal Growth Factor Receptor and the Changing Face of Oropharyngeal Cancer</title>
		<link>http://oralcancernews.org/wp/epidermal-growth-factor-receptor-and-the-changing-face-of-oropharyngeal-cancer/</link>
		<comments>http://oralcancernews.org/wp/epidermal-growth-factor-receptor-and-the-changing-face-of-oropharyngeal-cancer/#comments</comments>
		<pubDate>Fri, 09 Mar 2012 17:33:51 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemoradiotherapy]]></category>
		<category><![CDATA[epidermal growth factor receptor]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12620</guid>
		<description><![CDATA[Source: Journal of Clinical Oncology To the Editor: In their article, Chaturvedi et al1 document the rise in human papillomavirus (HPV) –associated cancers as a proportion of squamous cell carcinomas of the oropharynx over the last 25 years. The contemporary figures are mirrored by two recent British studies2,3 demonstrating that the majority of oropharyngeal cancers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/epidermal-growth-factor-receptor-and-the-changing-face-of-oropharyngeal-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Robotic surgery less invasive on HPV-related oral cancers</title>
		<link>http://oralcancernews.org/wp/robotic-surgery-less-invasive-on-hpv-related-oral-cancers/</link>
		<comments>http://oralcancernews.org/wp/robotic-surgery-less-invasive-on-hpv-related-oral-cancers/#comments</comments>
		<pubDate>Thu, 01 Mar 2012 23:21:18 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[Mayo Clinic]]></category>
		<category><![CDATA[oropharyngeal cancer]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[TransOral Robotic Surgery]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12577</guid>
		<description><![CDATA[Source: Dr.Bicuspid.com March 1, 2012 &#8212; Robotic surgery conducted through patients&#8217; mouths provides excellent results in removing squamous cell carcinoma at the back of the throat, especially in patients with HPV, according to a new Mayo Clinic study (Mayo Clinic Proceedings, March 2012, Vol. 87(3), pp. 211-212). &#8220;We were surprised that the cancer cure results [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/robotic-surgery-less-invasive-on-hpv-related-oral-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Adaptive radiotherapy may benefit patients with head and neck cancer</title>
		<link>http://oralcancernews.org/wp/adaptive-radiotherapy-may-benefit-patients-with-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/adaptive-radiotherapy-may-benefit-patients-with-head-and-neck-cancer/#comments</comments>
		<pubDate>Fri, 10 Feb 2012 17:40:11 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[Oropharynx]]></category>
		<category><![CDATA[radiotherapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[The Feinstein Institute for Medical Research]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12447</guid>
		<description><![CDATA[Source: News-Medical.net Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer. The trial, sponsored by the National Cancer Institute, provides evidence that ART may benefit patients [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/adaptive-radiotherapy-may-benefit-patients-with-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PET/CT Detects Early Recurrence of Head and Neck Cancer</title>
		<link>http://oralcancernews.org/wp/petct-detects-early-recurrence-of-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/petct-detects-early-recurrence-of-head-and-neck-cancer/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 18:43:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Society for Radiation Oncology]]></category>
		<category><![CDATA[chemoradiation]]></category>
		<category><![CDATA[Multidisciplinary Head and Neck Cancer Symposium]]></category>
		<category><![CDATA[salvage therapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12430</guid>
		<description><![CDATA[Source: Elsevier Global Medical News Routine use of positron emission tomography/computed tomography scans can detect locoregional recurrences of squamous cell carcinoma of the head and neck before they became clinically apparent, according to a retrospective chart review of 234 patients who had been treated with chemoradiation between 2006 and 2010.  The finding suggests that routine use [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/petct-detects-early-recurrence-of-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Head and neck cancer carries substantial comorbidity burden</title>
		<link>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/</link>
		<comments>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 17:16:32 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[comorbidity]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[oral cavity]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12428</guid>
		<description><![CDATA[Source: MedWire News People with head and neck cancer experience a high burden of both acute and chronic comorbidity, shows an analysis of a large Dutch population-based cohort. The researchers therefore advise clinicians to account for patients&#8217; comorbidity burden when assessing the risk-benefit profile for different treatment options. Sarah Landis (GlaxoSmithKline, London, UK) and co-workers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/head-and-neck-cancer-carries-substantial-comorbidity-burden/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Third Head and Neck Indication for Erbitux</title>
		<link>http://oralcancernews.org/wp/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/</link>
		<comments>http://oralcancernews.org/wp/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 18:03:40 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[colorectal cancer]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[squamous cell head and neck cancer]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12267</guid>
		<description><![CDATA[Source: The ASCO Post, January 1, 2012, Volume 3, Issue 1, Matthew Stenger &#160; In the Clinic provides overviews of novel oncology agents, addressing indications, mechanisms, administration recommendations, safety profiles, and other essential information needed for the appropriate clinical use of these drugs.Cetuximab (Erbitux) was recently approved by the FDA for use in combination with platinum-based therapy [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-indication-for-cetuximab-in-squamous-cell-carcinoma-of-the-head-and-neck/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Quality-of-Life Outcomes in Transoral Robotic Surgery</title>
		<link>http://oralcancernews.org/wp/quality-of-life-outcomes-in-transoral-robotic-surgery/</link>
		<comments>http://oralcancernews.org/wp/quality-of-life-outcomes-in-transoral-robotic-surgery/#comments</comments>
		<pubDate>Tue, 27 Dec 2011 17:58:43 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[TORS]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12227</guid>
		<description><![CDATA[Source: SAGE Journals Online Abstract Objective. To report long-term, health-related quality-of-life (HRQOL) outcomes in patients treated with transoral robotic surgery (TORS). Study Design. Prospective, longitudinal, clinical study on functional and HRQOL outcomes in TORS. Setting. University tertiary care facility. Subjects and Methods. Patients who underwent TORS were asked to complete a Head and Neck Cancer [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/quality-of-life-outcomes-in-transoral-robotic-surgery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Cetuximab for Late-Stage Head and Neck Cancer</title>
		<link>http://oralcancernews.org/wp/fda-approves-cetuximab-for-late-stage-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/fda-approves-cetuximab-for-late-stage-head-and-neck-cancer/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 18:05:16 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Bristol-Myers Squibb]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[colon cancer]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[Food and Drug Administration]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12059</guid>
		<description><![CDATA[Source: The Oncology Report The Food and Drug Administration on Nov. 7 approved cetuximab as an initial treatment of late-stage head and neck cancer in combination with chemotherapy. Cetuximab, marketed as Erbitux by Bristol-Myers Squibb, is an epidermal growth factor receptor (EGFR) antagonist, administered as an intravenous infusion. Previously, it was approved in combination with [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fda-approves-cetuximab-for-late-stage-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA Approves Cetuximab for Metastatic Head and Neck Cancer</title>
		<link>http://oralcancernews.org/wp/fda-approves-cetuximab-for-metastatic-head-and-neck-cancer/</link>
		<comments>http://oralcancernews.org/wp/fda-approves-cetuximab-for-metastatic-head-and-neck-cancer/#comments</comments>
		<pubDate>Tue, 08 Nov 2011 19:00:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Society of clinical oncology]]></category>
		<category><![CDATA[Bristol-Myers Squibb]]></category>
		<category><![CDATA[cetuximab]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[erbitux]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=12042</guid>
		<description><![CDATA[Source: MedScape News Today The US Food and Drug Administration (FDA) has approved cetuximab (Erbitux, Bristol-Myers Squibb ) for use in combination with chemotherapy for the treatment of metastatic head and neck cancer. Data show that when combined with cisplatin-based chemotherapy, cetuximab improved overall survival, compared with chemotherapy alone. According to the researchers, this is [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/fda-approves-cetuximab-for-metastatic-head-and-neck-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ethanol Promotes Chemically Induced Oral Cancer in Mice through Activation of the 5-Lipoxygenase Pathway of Arachidonic Acid Metabolism</title>
		<link>http://oralcancernews.org/wp/ethanol-promotes-chemically-induced-oral-cancer-in-mice-through-activation-of-the-5-lipoxygenase-pathway-of-arachidonic-acid-metabolism/</link>
		<comments>http://oralcancernews.org/wp/ethanol-promotes-chemically-induced-oral-cancer-in-mice-through-activation-of-the-5-lipoxygenase-pathway-of-arachidonic-acid-metabolism/#comments</comments>
		<pubDate>Wed, 19 Oct 2011 22:36:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[alcohol]]></category>
		<category><![CDATA[ethanol]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[oral carcinogenesis]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11943</guid>
		<description><![CDATA[Source: Cancer Prevention Research Abstract Alcohol drinking is a known risk factor for oral cancer in humans. However, previous animal studies on the promoting effect of ethanol on oral carcinogenesis were inconclusive. It is necessary to develop an animal model with which the molecular mechanism of ethanol-related oral carcinogenesis may be elucidated to develop effective [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/ethanol-promotes-chemically-induced-oral-cancer-in-mice-through-activation-of-the-5-lipoxygenase-pathway-of-arachidonic-acid-metabolism/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Resveratrol Selectively Induces DNA Damage, Independent of Smad4 Expression, in Its Efficacy against Human Head &amp; Neck Squamous Cell Carcinoma</title>
		<link>http://oralcancernews.org/wp/resveratrol-selectively-induces-dna-damage-independent-of-smad4-expression-in-its-efficacy-against-human-head-neck-squamous-cell-carcinoma/</link>
		<comments>http://oralcancernews.org/wp/resveratrol-selectively-induces-dna-damage-independent-of-smad4-expression-in-its-efficacy-against-human-head-neck-squamous-cell-carcinoma/#comments</comments>
		<pubDate>Mon, 15 Aug 2011 17:20:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Association for Cancer Research]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[hnscc cells]]></category>
		<category><![CDATA[oral cancer]]></category>
		<category><![CDATA[smad4]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[university of colorado]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11613</guid>
		<description><![CDATA[Source: Clinical Cancer Research Author: Robert A. Sclafani, University of Colorado School of Medicine, Campus Box 8101, Room 9100, Aurora, CO 80045. Phone: 303-724-3271; Fax: 303-724-3215; E-mail:Robert.Sclafani@ucdenver.edu &#160; Abstract Purpose: Alterations in Smad4 signaling and its loss cause genomic instability and head and neck squamous cell carcinoma (HNSCC), suggesting that agents that target both Smad4-dependent and -independent [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/resveratrol-selectively-induces-dna-damage-independent-of-smad4-expression-in-its-efficacy-against-human-head-neck-squamous-cell-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Study on Tonsillar Squamous Cell Carcinoma</title>
		<link>http://oralcancernews.org/wp/new-study-on-tonsillar-squamous-cell-carcinoma/</link>
		<comments>http://oralcancernews.org/wp/new-study-on-tonsillar-squamous-cell-carcinoma/#comments</comments>
		<pubDate>Tue, 02 Aug 2011 17:29:43 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[National Cancer Institute]]></category>
		<category><![CDATA[SEER]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11517</guid>
		<description><![CDATA[Source: SAGE Journals Online Objective. To analyze outcomes in patients with squamous cell carcinoma (SCCA) of the tonsil from the years 1998 to 2006. To assess factors that may affect disease-specific survival, such as patient characteristics and/or treatment modality. Study Design and Setting. National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) program. Subjects and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-study-on-tonsillar-squamous-cell-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Strategies used to Identify Changes in Head and Neck Cancers</title>
		<link>http://oralcancernews.org/wp/new-strategies-used-to-identify-changes-in-head-and-neck-cancers/</link>
		<comments>http://oralcancernews.org/wp/new-strategies-used-to-identify-changes-in-head-and-neck-cancers/#comments</comments>
		<pubDate>Wed, 08 Jun 2011 16:14:07 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team - A</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[American Association of Cancer Research]]></category>
		<category><![CDATA[American Society of clinical oncology]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[genes]]></category>
		<category><![CDATA[head and neck cancer]]></category>
		<category><![CDATA[Johns Hopkins University]]></category>
		<category><![CDATA[squamous cell carcinoma]]></category>
		<category><![CDATA[tumors]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=11221</guid>
		<description><![CDATA[Source: GenomeWeb Daily News By Andrea Anderson CHICAGO– Researchers are making progress using high-throughput strategies to find previously unappreciated genetic and epigenetic quirks in head and neck cancer — including changes that may prove useful for diagnosing and tracking disease. Johns Hopkins University head and neck cancer research director David Sidransky described some of the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/new-strategies-used-to-identify-changes-in-head-and-neck-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

